Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
Status:
Active, not recruiting
Trial end date:
2021-12-20
Target enrollment:
Participant gender:
Summary
Controlled, randomized phase III study, with the intent of optimizing the treatment of not
metastatic Ewing Sarcoma. The patients will be randomized into 2 arms: standard treatment vs
intensive treatment. Both arms will receive an induction treatment followed by surgery
(wherever is possible) and/or radiotherapy. The maintenance treatment will be different on
the basis of the response to the induction treatment (good or poor)